{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013059","form_type":"8-K","ticker":"LUCD","cik":"0001799011","company_name":"Lucid Diagnostics Inc.","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.759356+00:00","generated_at":"2026-05-20T04:37:55.744152+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lucid Diagnostics enters $25M ATM equity offering with Maxim Group","bullets":["Up to $25M of common stock may be sold at-the-market via Maxim Group as agent.","Agent commission set at 3% of gross proceeds; $60k legal fee reimbursement at signing.","Proceeds to be used for working capital and general corporate purposes.","Agreement dated May 30, 2025; offering under effective Form S-3 (File No. 333-268560).","Company may terminate agreement at any time with ten business days' notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013059","json":"https://secwatch.observer/filing/0001641172-25-013059.json","markdown":"https://secwatch.observer/filing/0001641172-25-013059.md","text":"https://secwatch.observer/filing/0001641172-25-013059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799011/000164117225013059/0001641172-25-013059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799011/000164117225013059/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:37:55.744152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}